Abstract:Several studies have proposed grading systems aimed at improving the stratification of risk factors for early lung adenocarcinoma, but the repeatability of high‐grade subtypes is unsatisfactory in clinical practice. In this study, we utilized machine learning algorithms and survival models to construct a novel grading system based on the percentages of lepidic, solid, micropapillary lesions and STAS in a cohort of patients with stage I invasive lung adenocarcinoma. Our study has great value in clinical applications since it is more compact, comprehensible, with better accuracy and reproducibility. Background Several studies have proposed grading systems for risk stratification of early‐stage lung adenocarcinoma based on histological patterns. However, the reproducibility of these systems is poor in clinical practice, indicating the need to develop a new grading system which is easy to apply and has high accuracy in prognostic stratification of patients. Methods Patients with stage I invasive nonmucinous lung adenocarcinoma were retrospectively collected from pathology archives between 2009 and 2016. The patients were divided into a training and validation set at a 6:4 ratio. Histological features associated with patient outcomes (overall survival [OS] and progression‐free survival [PFS]) identified in the training set were used to construct a new grading system. The newly proposed system was validated using the validation set. Survival differences between subgroups were assessed using the log‐rank test. The prognostic performance of the novel grading system was compared with two previously proposed systems using the concordance index. Results A total of 539 patients were included in this study. Using a multioutcome decision tree model, four pathological factors, including the presence of tumor spread through air space (STAS) and the percentage of lepidic, micropapillary and solid subtype components, were selected for the proposed grading system. Patients were accordingly classified into three groups: low, medium, and high risk. The high‐risk group showed a 5‐year OS of 52.4% compared to 89.9% and 97.5% in the medium and low‐risk groups, respectively. The 5‐year PFS of patients in the high‐risk group was 38.1% compared to 61.7% and 90.9% in the medium and low‐risk groups, respectively. Similar results were observed in the subgroup analysis. Additionally, our proposed grading system provided superior prognostic stratification compared to the other two systems with a higher concordance index. Conclusion The newly proposed grading system based on four pathological factors (presence of STAS, and percentage of lepidic, micropapillary, and solid subtypes) exhibits high accuracy and good reproducibility in the prognostic stratification of stage I lung adenocarcinoma patients.

Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma

The IASLC Grading System for Invasive Pulmonary Adenocarcinoma: a Potential Prognosticator for Patients Receiving Neoadjuvant Therapy

[Prognostic Significance of a Newly Proposed Grading and Scoring System in Stage I Pulmonary Adenocarcinoma].

Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma

Prognostic Significance of the IASLC/ATS/ERS Classification in Chinese Patients—a Single Institution Retrospective Study of 292 Lung Adenocarcinoma

Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system

P2.01-083 Prognostic Factors of Overall Survival in 150 Resected Lung Adenocarcinoma Patients: Topic: Marker for Prognosis

Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer

New Additional Scoring Formula on the Pathological Features in Stage I Lung Adenocarcinoma Patients: Impact on Survival

Novel Prognostic Model for Stratifying Survival in Stage I Lung Adenocarcinoma Patients

Percentage of Newly Proposed High-Grade Patterns Is Associated with Prognosis of Pathological T1-2N0M0 Lung Adenocarcinoma

Preoperative Prognostic Prediction for Stage I Lung Adenocarcinomas: Impact of the Computed Tomography Features Associated with the New Histological Grading System

Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma

Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study

[Analysis of the Effect of Different Pathological Subtypes to Prognosis in Stage I Pulmonary Adenocarcinoma].

Why Do Pathological Stage IA Lung Adenocarcinomas Vary from Prognosis?: a Clinicopathologic Study of 176 Patients with Pathological Stage IA Lung Adenocarcinoma Based on the IASLC/ATS/ERS Classification.

The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma

110P the Role of Extensive Lymph Node Dissection in the New Grading System for Lung Adenocarcinoma

The role of extensive lymph node dissection in the new grading system for lung adenocarcinoma

Prognostic Value of the International Association for the Study of Lung Cancer Grading System and its Association with the Tumor Microenvironment in Stage I EGFR-muted Lung Adenocarcinoma

Grading of Endocervical Adenocarcinoma: a Novel Prognostic System Based on Tumor Budding and Cell Cluster Size.